Bookmark
Forward
Explore Literature Results
Explore Clinical Trials Results
QuickView for very late antigen- 4
Most Relevant Literature
- Evaluation of Constitutive or Induced Activation State of the VLA-4 Integrin in Human and Murine Sam…
- DNA Aptamer-Polymer Conjugates for Selective Targeting of Integrin α4β1+ T-Lineage Cancers.
- ATG8 inhibited endometriosis formation by regulating Treg cells differentiation via integrin α4β1 an…
- Leishmania amazonensis infection impairs VLA-4 clustering and adhesion complex assembly at the adhes…
- VLA-4 as a Central Target for Modulating Neuroinflammatory Disorders.
Most Relevant Clinical Trials
- Bortezomib in Late Antibody-mediated Kidney Transplant Rejection
- The LAVA (Lateral Flow Antigen Validation and Applicability) Study for COVID-19
- Hypofractionated Radiotherapy (55 Gy/16 Fractions/4 Weeks) for Localized Prostate Cancer
- Study of Natalizumab in Relapsed/Refractory Multiple Myeloma
- Effect of BG00012 on Lymphocyte Subsets and Immunoglobulins in Subjects With Relapsing Remitting Mul…
